California Public Employees Retirement System leans harder into index beta and AI plumbing

The biggest dollar add was more S&P 500 exposure via VOO, up 6.5% with an estimated +$1.22B, plus a new IVV position at about $828.0M. That’s not a tactical trade; that’s a strategic reassertion of benchmark beta after a drawdown, consistent with a liability-driven allocator unwilling to time the market.

Within tech, conviction is clearly rising in the AI infrastructure layer. Lam Research was boosted +50.6% in shares (about +$421.4M), Micron +46.2% (around +$340.6M), and Intel +11.2%, even as the overall tech sector weight nudged slightly down. They are shifting from pure GPU exposure toward memory and wafer‑fab equipment that monetize the coming capex cycle.

The mega‑cap platform trade is not being abandoned; Apple and Microsoft both saw +3.7% share increases, adding roughly $339.7M and $289.5M respectively. Amazon was also lifted +8.7% despite being underwater at about -39.4% versus their average cost, signaling a willingness to average down into structurally growing consumer–cloud franchises.

Finance saw a quiet but notable vote of confidence through a +15.8% add to Goldman Sachs (about +$80.5M) and a modest increase in Wells Fargo. That pattern fits a view that higher-for-longer rates and capital markets activity still support bank earnings even if the macro tape is messy.

On the sell side, the loudest message is profit-taking in the biggest AI winner. Nvidia’s position was cut -10.5%, freeing up about $1.40B while the stake still sits on a roughly 224.8% gain versus cost — classic risk management after a vertical move, not a repudiation of AI.

Alphabet saw dual trims: GOOG down -16.5% (around -$584.6M) and GOOGL down -4.8% (about -$212.9M). Meta was also reduced modestly. That cluster says: take gains in hyper-profitable mega-cap tech to fund both index beta and more targeted AI infrastructure exposure.

Defensives and quasi-bond proxies were leaned on as funding sources. Pepsi was slashed -39.7% (roughly -$331.1M), Procter & Gamble, Coca‑Cola, and Verizon were all cut, indicating less enthusiasm for low-growth, rate-sensitive staples now that real yields are higher and growth tech has corrected.

Healthcare also provided liquidity. Johnson & Johnson was trimmed -19.4% (about -$353.0M), Merck -13.8% (around -$142.6M), and ABBVie and Amgen saw smaller cuts, collectively taking Health Care from 6.95% to 6.29% of the book. This looks less like a call on drug pipelines and more like de‑risking a crowded defensive trade to back higher-conviction growth exposures.

Even Berkshire Hathaway was reduced -18.0% (about -$292.3M), a notable choice to redirect capital from a broad conglomerate proxy to more precise sector and factor bets elsewhere in the portfolio.

Despite all the noise, the sector split didn’t blow up; it tilted. Technology slipped only marginally from 48.98% to 48.24%, but the internal rotation was meaningful: out of Nvidia and older hardware like IBM, into memory, equipment, and core platforms such as Apple and Microsoft.

Unclassified vehicles — mostly broad index and multi-asset funds like VOO, JPHY, IVV and Berkshire — climbed from 21.18% to 23.05%. That’s the real macro call: CalPERS wants more diversified, rules-based exposure rather than letting a handful of stocks drive tracking error.

Healthcare shrank from 6.95% to 6.29%, with consistent trims across JNJ, Merck, AbbVie and UNH. Consumer Staples dropped from 1.5% to 1.2%, anchored by that large Pepsi cut, while Consumer Discretionary was effectively flat at 8.89%, with Costco and Home Depot trims offset by incremental adds to Walmart and Amazon.

Financials barely moved in aggregate (3.75% to 3.69%), but composition shifted: less JPMorgan and Bank of America, slightly more Goldman Sachs and Wells Fargo. Telecom exposure declined from 1.65% to 1.58% as Verizon was reduced, partially offset by a small Cisco add.

Energy, Industrials, and Real Estate exposures were essentially stable in headline terms. Within them, CalPERS showed a slight bias toward industrial cyclicals (small adds to Caterpillar and Deere) and incremental support for integrated oils via a modest Chevron increase.

Put together, the quarter reads as a re‑underwriting of the equity bull case, not a retreat. After an -8.75% period, they increased S&P 500 exposure via VOO and IVV rather than trying to time a recession, signaling confidence in long-run U.S. earnings power.

Within AI, the bet is evolving from hero stocks to the supply chain. Trimming Nvidia and Alphabet to fund Lam Research, Micron, Intel and still-additive stakes in Apple and Microsoft says they want durable participation in AI capex and platform monetization, not to live or die by one GPU name.

The big cuts in Pepsi, Johnson & Johnson, and other defensives show a clear willingness to sacrifice perceived safety for higher expected return per unit of risk. They’re effectively saying that bond‑like equities are less attractive in a world where real yields are higher and growth franchises have repriced.

At the margin, the tweaks in banks, industrials, and energy point to a belief that the cycle isn’t about to roll over. Adding to Goldman Sachs and Wells Fargo, plus slight increases in Caterpillar, Deere and Chevron, hints at expectations of ongoing capital spending, resilient credit quality, and continued demand for hard assets.

Going forward, expect CalPERS to keep this barbell: large and growing index cores doing the heavy lifting, surrounded by concentrated tilts in AI infrastructure, platform tech, and select cyclicals. The message to the tape is clear: embrace volatility, but diversify how you get paid for it.